<fo:root font-family="TimesNewRoman" xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:w="http://schemas.microsoft.com/office/word/2003/wordml"><fo:layout-master-set xmlns:rx="http://www.renderx.com/XSL/Extensions" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:wx="http://schemas.microsoft.com/office/word/2003/auxHint" xmlns:aml="http://schemas.microsoft.com/aml/2001/core" xmlns:w10="urn:schemas-microsoft-com:office:word" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"><fo:simple-page-master master-name="section1-first-page" page-width="8.5in" page-height="11in" margin-top="36pt" margin-bottom="36pt" margin-right="54pt" margin-left="90pt"><fo:region-body margin-top="22.5pt" margin-bottom="36pt"></fo:region-body><fo:region-before region-name="first-page-header" extent="11in"></fo:region-before><fo:region-after region-name="first-page-footer" extent="11in" display-align="after"></fo:region-after></fo:simple-page-master><fo:simple-page-master master-name="section1-odd-page" page-width="8.5in" page-height="11in" margin-top="36pt" margin-bottom="36pt" margin-right="54pt" margin-left="90pt"><fo:region-body margin-top="22.5pt" margin-bottom="36pt"></fo:region-body><fo:region-before region-name="odd-page-header" extent="11in"></fo:region-before><fo:region-after region-name="odd-page-footer" extent="11in" display-align="after"></fo:region-after></fo:simple-page-master><fo:simple-page-master master-name="section1-even-page" page-width="8.5in" page-height="11in" margin-top="36pt" margin-bottom="36pt" margin-right="54pt" margin-left="90pt"><fo:region-body margin-top="22.5pt" margin-bottom="36pt"></fo:region-body><fo:region-before region-name="even-page-header" extent="11in"></fo:region-before><fo:region-after region-name="even-page-footer" extent="11in" display-align="after"></fo:region-after></fo:simple-page-master><fo:page-sequence-master master-name="section1-page-sequence-master"><fo:single-page-master-reference master-reference="section1-first-page" /><fo:repeatable-page-master-alternatives><fo:conditional-page-master-reference odd-or-even="odd" master-reference="section1-odd-page" /><fo:conditional-page-master-reference odd-or-even="even" master-reference="section1-even-page" /></fo:repeatable-page-master-alternatives></fo:page-sequence-master></fo:layout-master-set><fo:page-sequence master-reference="section1-page-sequence-master" id="IDAFIU0B" format="1" xmlns:rx="http://www.renderx.com/XSL/Extensions" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:wx="http://schemas.microsoft.com/office/word/2003/auxHint" xmlns:aml="http://schemas.microsoft.com/aml/2001/core" xmlns:w10="urn:schemas-microsoft-com:office:word" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"><fo:static-content flow-name="first-page-header"><fo:retrieve-marker retrieve-class-name="first-page-header" retrieve-position="first-including-carryover" retrieve-boundary="page" /></fo:static-content><fo:static-content flow-name="first-page-footer"><fo:retrieve-marker retrieve-class-name="first-page-footer" retrieve-position="first-including-carryover" retrieve-boundary="page" /></fo:static-content><fo:static-content flow-name="odd-page-header"><fo:retrieve-marker retrieve-class-name="odd-page-header" retrieve-position="first-including-carryover" retrieve-boundary="page" /></fo:static-content><fo:static-content flow-name="odd-page-footer"><fo:retrieve-marker retrieve-class-name="odd-page-footer" retrieve-position="first-including-carryover" retrieve-boundary="page" /></fo:static-content><fo:static-content flow-name="even-page-header"><fo:retrieve-marker retrieve-class-name="odd-page-header" retrieve-position="first-including-carryover" retrieve-boundary="page" /></fo:static-content><fo:static-content flow-name="even-page-footer"><fo:retrieve-marker retrieve-class-name="odd-page-footer" retrieve-position="first-including-carryover" retrieve-boundary="page" /></fo:static-content><fo:static-content flow-name="xsl-footnote-separator"><fo:block><fo:leader leader-pattern="rule" leader-length="144pt" rule-thickness="0.5pt" rule-style="solid" color="gray" /></fo:block></fo:static-content><fo:flow flow-name="xsl-region-body"><fo:block widows="2" orphans="2" font-size="10pt" line-height="1.147" white-space-collapse="false"><fo:marker marker-class-name="first-page-header" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg" /><fo:marker marker-class-name="first-page-footer" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg" /><fo:marker marker-class-name="odd-page-header" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg" /><fo:marker marker-class-name="odd-page-footer" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" space-before="0pt" space-after="0pt"><fo:inline><fo:leader leader-length="0pt" /><fo:page-number /></fo:inline></fo:block></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" end-indent="18pt"><fo:leader /></fo:block></fo:marker><fo:marker marker-class-name="even-page-header" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg" /><fo:marker marker-class-name="even-page-footer" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" space-before="0pt" space-after="0pt"></fo:block></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" end-indent="18pt"><fo:leader /></fo:block></fo:marker><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline><fo:leader leader-length="0pt" />Please note the following information about your approved research protocol:</fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />If not applicable </fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />–</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" /> </fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />delete - </fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />do not include</fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Research Protocol:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />(description/sponsor, version #, date of protocol)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Sponsor:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="FUNDING_SOURCE" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Approved Enrollment  #:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="APP_SUBJECTS" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Participant Population:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="SUBJECTS" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Performance Sites:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="SITES" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />In</fo:inline><fo:inline><fo:leader leader-length="0pt" />vestigational Drug:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="INV_DRUG" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Investigational Drug Brochure:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />(version, date)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Investigational Device:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="INV_DEVICE" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline><fo:leader leader-length="0pt" />Device Risk Determination:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline id="SIG_RISK" /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline background-color="lime"><fo:leader leader-length="0pt" />Expedited Category(</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />ies</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />):</fo:inline><fo:inline background-color="lime"><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline background-color="lime"><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader><fo:leader leader-length="0pt" />45 CFR 46.110(b)(enter category number) and/or 21 CFR 56.110(b</fo:inline><fo:inline background-color="aqua"><fo:leader leader-length="0pt" />)(</fo:inline><fo:inline font-weight="bold" background-color="aqua"><fo:leader leader-length="0pt" />include for initial approvals done by expedited review</fo:inline><fo:inline font-weight="bold" background-color="aqua"><fo:leader leader-length="0pt" /> – all other reviews, including renewals and amendments, delete this bullet</fo:inline><fo:inline font-weight="bold" background-color="aqua"><fo:leader leader-length="0pt" />)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label background-color="lime" start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline background-color="lime"><fo:leader leader-length="0pt" />(</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />UMC or Sponsor</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />) Amendment #:</fo:inline><fo:inline background-color="lime"><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader><fo:leader leader-length="0pt" />(amendment number</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" /> – for sponsored studies include whatever the sponsor calls this, whether amendment, revision or something else</fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US"><fo:list-item-label start-indent="0pt" text-indent="0pt" font-family="Symbol"><fo:block>•</fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="18pt" text-indent="0pt"><fo:block><fo:inline id="EXPEDITED_CATEGORY" /><fo:inline><fo:leader leader-length="0pt" />Amendment Description:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline background-color="lime"><fo:leader leader-length="0pt" />(short description)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" start-indent="162pt" text-indent="18pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline id="SUBMISSION_TYPE2" /><fo:inline><fo:leader leader-length="0pt" /> Review History:</fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline><fo:inline><fo:leader leader-pattern="use-content" leader-length="35.25pt"> </fo:leader></fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline background-color="lime"><fo:leader leader-length="0pt" />Formatting Note: Select all the history rows, from the Table menu item select 'Convert text to table', and Press OK</fo:inline><fo:inline><fo:leader leader-length="0pt" />.</fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline id="REVIEW_HISTORY" /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline id="IRB1" /><fo:inline><fo:leader leader-length="0pt" />ENCLOSURES</fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline /><fo:inline /><fo:inline /><fo:inline /><fo:inline /></fo:block><fo:block font-family="'GVTerminal','CourierNew'" font-size="12pt" language="EN-US" widows="1" orphans="1" start-indent="90pt" text-indent="-90pt" end-indent="-18pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline font-family="Arial"><fo:leader leader-length="0pt" />Enclosure(s): (1) Investigator Responsibilities, Protection of Human Research </fo:inline><fo:inline font-family="Arial"><fo:leader leader-length="0pt" />P</fo:inline><fo:inline font-family="Arial"><fo:leader leader-length="0pt" />articipants</fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="'GVTerminal','CourierNew'" font-size="12pt" language="EN-US" widows="1" orphans="1" start-indent="36pt" text-indent="-36pt"><fo:list-item-label font-family="Arial" start-indent="73.5pt" text-indent="0pt" font-size="12pt"><fo:block><fo:inline>(2)</fo:inline></fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="91.5pt" text-indent="0pt"><fo:block><fo:inline font-family="Arial"><fo:leader leader-length="0pt" />Recruit</fo:inline><fo:inline font-family="Arial"><fo:leader leader-length="0pt" />ment</fo:inline><fo:inline font-family="Arial"><fo:leader leader-length="0pt" /> Material – </fo:inline><fo:inline font-family="Arial" background-color="lime"><fo:leader leader-length="0pt" />(add description, version # and date)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="'GVTerminal','CourierNew'" font-size="12pt" language="EN-US" widows="1" orphans="1" start-indent="36pt" text-indent="-36pt"><fo:list-item-label font-family="Arial" font-size="12pt" start-indent="73.5pt" text-indent="0pt"><fo:block><fo:inline>(3)</fo:inline></fo:block></fo:list-item-label><fo:list-item-body end-indent="inherit" start-indent="91.5pt" text-indent="0pt"><fo:block><fo:inline font-family="Arial"><fo:leader leader-length="0pt" />Optional Form 310 - </fo:inline><fo:inline font-family="Arial" font-size="10pt"><fo:leader leader-length="0pt" />Protection of Human Subjects, Assurance Identification/Certification/Declaration </fo:inline><fo:inline font-family="Arial" background-color="lime"><fo:leader leader-length="0pt" />(If federally supported)</fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" text-align="center" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline><fo:leader /><fo:block break-before="page" /></fo:inline><fo:inline font-weight="bold" color="black" font-size="18pt"><fo:leader leader-length="0pt" />UMMC Investigator Responsibilities </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" text-align="center" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline font-weight="bold" color="black" font-size="18pt"><fo:leader leader-length="0pt" />Protection of Human Research Participants</fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" />The IRB reviews research to ensure that the federal regulations for protecting human research participants outlined in UMMC policy, the Department of Health and Human Services (DHHS) regulations (45 CFR 46) and the Food and Drug Administration (FDA) regulations (21 CFR Parts 50 &amp; 56), as well as other requirements, are met.  The University </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />of</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> Mississippi Medical Center’s </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />Federalwide</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> Assurance (FWA), FWA# 00003630, awarded by the Office for Human Research Protections (OHRP) at DHHS, is a written pledge to follow federal guidelines for protecting human research participants in accordance with the principles of the Belmont Report. </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />All investigators must read both the </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />Belmont</fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" /> Report and the UMMC FWA to understand their responsibilities in conducting research involving human participants</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />.  Both documents are available on the Human Research Office webpage, </fo:inline><fo:basic-link external-destination="url(&quot;http://irb.umc.edu/&quot;)"><fo:inline color="#0000FF" text-decoration="underline"><fo:leader leader-length="0pt" />http://irb.umc.edu/</fo:inline></fo:basic-link><fo:inline color="black"><fo:leader leader-length="0pt" /> , and in hard copy by request from the Human Research Office. Some of the responsibilities investigators have when conducting research involving human participants are listed below. </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />1. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Conducting the Research:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> You are responsible for making sure that the research is conducted according to the IRB approved research protocol. </fo:inline><fo:inline font-weight="bold" color="black" text-decoration="underline"><fo:leader leader-length="0pt" />You are also responsible for the actions of the study’s co-investigators and research staff</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" space-after="6pt" space-after.conditionality="retain" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />2. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Participant Enrollment:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> You may not recruit or enroll participants prior to the IRB approval date or after the expiration date of IRB approval.  All recruitment materials for any form of distribution or media use must be approved by the IRB prior to their use. If you need to recruit more participants than was noted in your IRB approval letter, you must submit an amendment requesting an increase in the number of participants.  </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />3. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Informed Consent:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> Informed consent is a process that begins with the initial contact and ends at some point after the study is complete.  You are responsible for the conduct of the consent process, ensuring that effective informed consent is obtained and documented using </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />only</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> the IRB-approved and stamped consent document(s), and for ensuring that no human participants are involved in research prior to obtaining their informed consent.  Whoever is presenting the consent document to the potential participant and conducting the consent discussion must have all pertinent information at hand, be knowledgeable about the study and the disease or condition involved, if any, and have the ability and experience to answer questions regarding the study and any treatment involved.  Please give all participants a signed copy </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />of each consent</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> or assent document they sign, and keep the originals in your secured research files for at least six (6) years.  When appropriate, you should place a copy of the consent document in the participant’s medical record. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />4. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Continuing Review:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> The IRB must review and approve all IRB-approved research protocols at intervals appropriate to the degree of risk, but not less than once per year.  </fo:inline><fo:inline font-weight="bold" color="black" text-decoration="underline"><fo:leader leader-length="0pt" />There is no grace period</fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />.</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  Prior to the date on which IRB approval of the research expires, the IRB will send you three reminders to submit a Continuing Review, 90, 60 and 30 days prior to expiration.  Although reminders are sent, </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />it is ultimately your responsibility to submit the renewal in a timely fashion to ensure that a lapse in IRB approval does not occur. </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> If IRB approval of your research lapses, you must stop new participant enrollment, and contact the IRB immediately. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />5. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Amendments and Revisions:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  If you wish to amend or change any aspect of your research, including research design, interventions or procedures, number of participants, participant population, consent document, instruments, surveys or recruitment and retention material, you must submit the amendment or revisions to the IRB for review with a Request for Change. You</fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" /> may not initiate</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> any amendments or changes to your research without first obtaining IRB review and written approval.  The </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />only exception</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> is when the change is necessary to eliminate apparent immediate hazard to participants.  In that case the IRB should be immediately informed of this necessity, but the change may be implemented before obtaining IRB approval. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />6. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Unanticipated Events:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  All adverse events that are unanticipated </fo:inline><fo:inline font-weight="bold" color="black" text-decoration="underline"><fo:leader leader-length="0pt" />(unanticipated means that the event is serious,</fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" /> </fo:inline><fo:inline font-weight="bold" color="black" text-decoration="underline"><fo:leader leader-length="0pt" />unexpected, related or possibly related to participation in the study and places participants at greater risk of harm than previously recognized)</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> and serious protocol </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />deviations,</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> must be reported to the IRB </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />within ten (10) business days </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />of discovery. The only exception to this policy is death - </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />the death of a UMMC research participant must be reported within 48 hours of discovery.</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  Reportable events should be submitted to the IRB with the Adverse Event/Unanticipated Problem Report form.  </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" start-indent="18pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline><fo:leader leader-length="0pt" />Events that do not meet the definition of an unanticipated problem involving risk to participants or others, including r</fo:inline><fo:inline><fo:leader leader-length="0pt" />esearch related injury occurring at a UMMC performance site or to a UMMC study participant</fo:inline><fo:inline><fo:leader leader-length="0pt" />, </fo:inline><fo:inline><fo:leader leader-length="0pt" />participant complaints</fo:inline><fo:inline><fo:leader leader-length="0pt" />,</fo:inline><fo:inline><fo:leader leader-length="0pt" /> problems</fo:inline><fo:inline><fo:leader leader-length="0pt" />, minor protocol deviations and</fo:inline><fo:inline><fo:leader leader-length="0pt" /> non-compliance with the IRB’s requirements for protecting human research participants</fo:inline><fo:inline><fo:leader leader-length="0pt" /> should be reported as follows:  Minor deviations and problems should be submitted at the time of continuing review, as instructed on the form.  All other events should be reported in writing via letter or email to the IRB with sufficient detail to allow the reviewer to understand the problem and any actions taken to prevent it from happening again.</fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:leader /></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader /><fo:block break-before="page" /></fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />7. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Research Record Keeping:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> At a minimum, you must keep the following research related records in a secure location for at least six years: the IRB approved research protocol and all amendments; all versions of the investigator’s brochure; all informed consent documents; all recruiting materials; all renewal applications; all adverse or unanticipated event reports; all correspondence to and from the IRB; and all raw data. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />8. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Reports to FDA and Sponsor:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  When you submit the required annual report to the FDA or you submit required reports to your sponsor, you </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />must</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> provide a copy of that report to the IRB.  You may submit the report with your IRB continuing review application. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />9. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Provision of Emergency Medical Care:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> When a physician provides emergency medical care to a participant without prior IRB review and approval, to the extent permitted by law, such activities will not be recognized as research and the data cannot be used in support of the research. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />10. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />Final Reports:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  When you have completed the study, (no further participant enrollment, interactions, interventions or data analysis) or stopped work on it, you must submit a Final Report to the IRB using the Final Report form. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:list-block xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:list-item font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" start-indent="18pt" end-indent="-7pt" text-indent="-18pt"><fo:list-item-label font-family="Arial" font-size="12pt" text-indent="0pt" start-indent="18pt" /><fo:list-item-body end-indent="-7pt" start-indent="18pt" text-indent="-18pt"><fo:block><fo:inline color="black"><fo:leader leader-length="0pt" />11. </fo:inline><fo:inline color="black" text-decoration="underline"><fo:leader leader-length="0pt" />On-Site Evaluations, FDA Inspections, or Audits:</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />  If you are notified that your research will be reviewed or audited by the FDA, OHRP, the sponsor, any other external agency, or any internal group, you </fo:inline><fo:inline font-weight="bold" color="black"><fo:leader leader-length="0pt" />must </fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" />inform the IRB immediately and submit all audit reports received as a result of the audit to the IRB. </fo:inline></fo:block></fo:list-item-body></fo:list-item></fo:list-block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline><fo:inline font-style="italic" color="black"><fo:leader leader-length="0pt" />If you have questions or need assistance, please contact the Human Research Office at 601 984-2815.</fo:inline><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" end-indent="-7pt" text-align="justify" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" widows="1" orphans="1" color="#000000" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:inline color="black"><fo:leader leader-length="0pt" /> </fo:inline></fo:block><fo:block id="IDAWQCLE" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns:svg="http://www.w3.org/2000/svg"><fo:block id="IDAWQCLE" /><fo:block font-family="TimesNewRoman" font-size="12pt" language="EN-US" keep-with-next.within-page="always" widows="1" orphans="1" font-weight="bold" text-align="center"><fo:leader /></fo:block><fo:block font-family="Arial" font-size="12pt" language="EN-US" end-indent="-7.2pt" text-align="justify"><fo:leader /></fo:block></fo:block></fo:block><fo:block id="IDACIU0B" /></fo:flow></fo:page-sequence></fo:root>